Form 4: Prestige Consumer Healthcare CEO Trades Shares

Ronald M. Lombardi, CEO of Prestige Consumer Healthcare Inc. (PBH), reported a transaction involving the purchase of 2,665 shares of common stock.

Summary

• Ronald M. Lombardi, Chief Executive Officer and Director of Prestige Consumer Healthcare Inc. (PBH), executed a transaction on May 2, 2026.
• The transaction involved the acquisition of 2,665 shares of common stock at a price of $55.09 per share.
• Following this transaction, Mr. Lombardi beneficially owns 343,864 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction without providing new financial or strategic information.

Positives

• CEO's direct purchase of company stock can signal confidence in the company's future prospects.
• The acquisition of 2,665 shares indicates a personal investment by a key executive.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Such transactions, particularly purchases by senior management, are often scrutinized by investors as potential indicators of management's belief in the company's valuation and future performance.

Stakeholder Impact

• Shareholders: May interpret the CEO's stock purchase as a positive signal of confidence in the company's value.
• Employees: May view the CEO's investment as a sign of stability and commitment from leadership.
• Creditors: The transaction does not directly impact creditor relationships.

Key Dates

Keywords

SEC Form 4, Insider Trading, Prestige Consumer Healthcare, PBH, Ronald M. Lombardi, Stock Transaction, Beneficial Ownership